Generic placeholder image

Current Drug Safety

Editor-in-Chief

ISSN (Print): 1574-8863
ISSN (Online): 2212-3911

A Case of Topiramate-Induced Epistaxis

Author(s): Giovanni Polimeni, Rosario Grugno, Antongiulio Vitetta, Francesco Cordici, Antonella Alagna, Achille P. Caputi and Placido Bramanti

Volume 4, Issue 3, 2009

Page: [207 - 208] Pages: 2

DOI: 10.2174/157488609789007001

Price: $65

Abstract

The current case describes epistaxis in a patient treated with a daily regimen of topiramate 100mg for migraine. The patient had not a past medical history of nosebleeds and laboratory parameters were within normal ranges. She was then advised to withdraw topiramate, and the epistaxis resolved within 12 hours after its discontinuation. Since then, the patient never complained other blood clotting disorders. The potential antiplatelet activity of topiramate is discussed.

Keywords: Topiramate, epistaxis, calcium-channel blockers, blood clotting


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy